Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression

标题
Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
作者
关键词
2019-Coronavirus disease, Lopinavir, Asymptomatic infection, Eosinophil
出版物
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 95, Issue -, Pages 183-191
出版商
Elsevier BV
发表日期
2020-03-13
DOI
10.1016/j.ijid.2020.03.013

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started